Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
28 results
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
D2.426 - Polarization of PBMCs during SARS-CoV-2 Infections
D2.432 - Therapeutic Efficacy of Platelet-Rich Plasma in Androgenic Alopecia: A Meta-Analysis of Single Versus Double-Blinded Randomized Controlled Trials
D2.423 - Changes in the expression of regulatory receptors on CD8+ T cytotoxic lymphocytes as a marker of the risk of developing a post COVID-19 condition in patients after a severe course of COVID-19
D2.425 - Type 2 neuro-immune signaling is upregulated in Candida albicans-driven itch
D2.427 - Inhibition of the IL-17 pathway in the treatment of systemic vasculitis: molecular biology and case review
D2.428 - Contribution of Allelic Gene Variants of the Indoleamine-2,3-Dioxygenase and Dectin-1 to the Risk of Invasive Aspergillosis in Oncohematological Patients
D2.429 - Virus-Specific Regulatory T-Cell Dysregulation in Post-COVID-19 and EBV-Associated Vasculitis
D2.430 - Automated 24-Hour Quantification of Scratching Behavior Reveals Distinct Physiological and Allergic Pruritus Signatures in Mice
D2.433 - Clinical and Oxidative Function Profiles in Heterozygous Female Carriers of X-Linked Chronic Granulomatous Disease
D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study
D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study
D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma
D3.111 - The Impact of War on the Course of Asthma
D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations
D3.113 - The Diagnostic Value of Exercise Bronchial Provocation Testing in Pediatric Asthma
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download